BacBench antibiotic resistance, MIC regression Pearson correlation
BacBench antibiotic resistance, MIC regression Pearson correlation as measured in the Bacformer preprint benchmark.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
12 recorded evaluations, 12 metric rows. A comparison chart has not yet been validated for these results. The table retains the individual findings and their sources.
Results
Results are available, but no reviewed comparison panel is linked in this release.
All evaluations
12 evaluations · 12 results. Different protocols are not a single leaderboard.
Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation · Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics
Sorted by Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.
All 12 result rows with coverage, uncertainty and sources
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: Bacformer Large (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 65.73 ± 12.88 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 12.88. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBacformer Large on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'Bacformer Large', column 'Regression Pearson' |
| Configuration: Bacformer (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 57.53 ± 15.43 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 15.43. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBacformer on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'Bacformer', column 'Regression Pearson' |
| Configuration: DNABERT-2 (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 45.89 ± 19.27 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 19.27. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceDNABERT-2 on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'DNABERT-2', column 'Regression Pearson' |
| Configuration: ESM-2 (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 54.60 ± 16.15 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 16.15. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM-2 on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'ESM-2', column 'Regression Pearson' |
| Configuration: ESM-C (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 56.79 ± 15.46 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 15.46. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceESM-C on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'ESM-C', column 'Regression Pearson' |
| Configuration: Evo-2 (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 00.53 ± 00.72 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 00.72. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceEvo-2 on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'Evo-2', column 'Regression Pearson' |
| Configuration: Evo (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 29.18 ± 17.26 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 17.26. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceEvo on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'Evo', column 'Regression Pearson' |
| Configuration: gLM2 (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 49.41 ± 17.14 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 17.14. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourcegLM2 on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'gLM2', column 'Regression Pearson' |
| Configuration: Mistral-DNA (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 40.95 ± 21.51 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 21.51. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceMistral-DNA on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'Mistral-DNA', column 'Regression Pearson' |
| Configuration: Nucleotide Transformer (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 51.19 ± 16.76 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 16.76. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceNucleotide Transformer on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'Nucleotide Transformer', column 'Regression Pearson' |
| Configuration: ProkBERT (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 51.24 ± 16.91 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 16.91. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceProkBERT on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'ProkBERT', column 'Regression Pearson' |
| Configuration: ProtBERT (frozen embeddings with a trained linear head) | Protocol: BacBench antibiotic resistance, MIC regression Pearson correlation Dataset subset: Antibiotic resistance MIC regression subset, 56 antibiotics | 51.56 ± 17.61 Pearson (linear head per drug on frozen genome embeddings predicting log(1+MIC), random 70/10/20 split, mean over 56 antibiotics, printed as a percentage) unitless · higher Uncertainty: SD 17.61. The caption says the spread is across antibiotics; the Methods state 37 antibiotics in the binary setting and 56 in the regression setting. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceProtBERT on BacBench antibiotic resistance, MIC regression Pearson correlation One linear model per drug on mean-pooled whole-genome embeddings: a single layer preceded by dropout of 0.1 and layer normalisation, binary cross-entropy for the resistant or susceptible setting and mean squared error for the log(1+MIC) regression, at most 100 epochs, early stopping patience 10 on validation AUROC or validation R squared, a learning-rate sweep per model across seeds and drugs, Adam with weight decay 0.01, and three random splits. Aggregation: Not reported Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Table S18, row 'ProtBERT', column 'Regression Pearson' |
Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.
Methods and evaluation design
Procedure, tasks and evaluated configurations
Recorded evaluations
Each evaluation records what was tested and under which conditions.
- Bacformer Large on BacBench antibiotic resistance, MIC regression Pearson correlation
- Bacformer on BacBench antibiotic resistance, MIC regression Pearson correlation
- DNABERT-2 on BacBench antibiotic resistance, MIC regression Pearson correlation
- ESM-2 on BacBench antibiotic resistance, MIC regression Pearson correlation
- ESM-C on BacBench antibiotic resistance, MIC regression Pearson correlation
- Evo-2 on BacBench antibiotic resistance, MIC regression Pearson correlation
- Evo on BacBench antibiotic resistance, MIC regression Pearson correlation
- gLM2 on BacBench antibiotic resistance, MIC regression Pearson correlation
- Mistral-DNA on BacBench antibiotic resistance, MIC regression Pearson correlation
- Nucleotide Transformer on BacBench antibiotic resistance, MIC regression Pearson correlation
- ProkBERT on BacBench antibiotic resistance, MIC regression Pearson correlation
- ProtBERT on BacBench antibiotic resistance, MIC regression Pearson correlation
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.
- Author-reported evaluations
- 12
Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.
Null control
Proposed control: requires review
Training-set mean where supervised fitting is permitted
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Conventional reference
Proposed control: requires review
Simple features with train-only ridge regression
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)
Coverage is derived from release 2026-11-21-adc15377fab2. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run instructions
No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-11-21-adc15377fab2 · Record review: source checked
1 source record and release history
- Bacformer preprint, bioRxiv 2025.07.20.665723 version 3 · Original source · Version 3, posted 17 August 2026 according to the page banner; the bioRxiv API lists version 3 with date 2026-08-19
Technical metadata and record identifiers
Technical metadata for this record is tracked under stable ID bacformer-20261115-protocol-amr-regression-pearson.
Source locator: Table S18, column 'Regression Pearson'
Related records
- part of: BacBench
- evaluates task: BacBench Antibiotic resistance prediction
- uses data: Antibiotic resistance MIC regression subset, 56 antibiotics
- assessment: Bacformer Large on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: Bacformer on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: DNABERT-2 on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: ESM-2 on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: ESM-C on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: Evo-2 on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: Evo on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: gLM2 on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: Mistral-DNA on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: Nucleotide Transformer on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: ProkBERT on BacBench antibiotic resistance, MIC regression Pearson correlation
- assessment: ProtBERT on BacBench antibiotic resistance, MIC regression Pearson correlation